Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis
Celia Camacho-Toledano, Isabel Machín-Díaz, Leticia Calahorra, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 9

Showing 9 citing articles:

Detection of Monocytic Myeloid-Derived Suppressor Cells in the Human Brain and Blood
María Cristina Ortega, Virginia Vila‐del Sol, Isabel Machín-Díaz, et al.
Methods in molecular biology (2025), pp. 89-109
Closed Access
Central and peripheral myeloid-derived suppressor cell-like cells are closely related to the clinical severity of multiple sclerosis
María Cristina Ortega, Rafael Lebrón‐Galán, Isabel Machín-Díaz, et al.
Acta Neuropathologica (2023) Vol. 146, Iss. 2, pp. 263-282
Open Access | Times Cited: 11
Myeloid‐derived suppressor cells in the therapy of autoimmune diseases
Marina Bekić, Sergej Tomić
European Journal of Immunology (2023) Vol. 53, Iss. 12
Open Access | Times Cited: 10
The Influence of Myeloid-Derived Suppressor Cell Expansion in Neuroinflammation and Neurodegenerative Diseases
Lorenza Tamberi, Alessia Belloni, Armanda Pugnaloni, et al.
Cells (2024) Vol. 13, Iss. 7, pp. 643-643
Open Access | Times Cited: 3
Diverse functions of myeloid-derived suppressor cells in autoimmune diseases
Xin Xiong, Yang Zhang, Yu Wen
Immunologic Research (2023) Vol. 72, Iss. 1, pp. 34-49
Open Access | Times Cited: 8
Response to Fingolimod in Multiple Sclerosis Patients Is Associated with a Differential Transcriptomic Regulation
Alicia Sánchez-Sanz, Rafael Muñoz‐Viana, Julia Sabín-Muñoz, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1372-1372
Open Access | Times Cited: 2
Graphene oxide films as a novel tool for the modulation of myeloid-derived suppressor cell activity in the context of multiple sclerosis
Celia Camacho-Toledano, Isabel Machín-Díaz, Rafael Lebrón‐Galán, et al.
Nanoscale (2024) Vol. 16, Iss. 15, pp. 7515-7531
Open Access | Times Cited: 1
The Role of Myeloid-Derived Suppressor Cells in Multiple Sclerosis and Its Animal Model
Qianling Jiang, Jielin Duan, Luc Van Kaer, et al.
Aging and Disease (2023)
Open Access | Times Cited: 3
Myeloid-derived Suppressor Cells and Multiple Sclerosis
Aurora Zanghì, Paola Sofia Di Filippo, Carlo Avolio, et al.
Current Neuropharmacology (2024) Vol. 23, Iss. 1, pp. 36-57
Closed Access
Circulating Myeloid-Derived Suppressor Cell load and disease severity are associated to an enhanced oligodendroglial production in a murine model of multiple sclerosis
Mari Paz Serrano‐Regal, Celia Camacho-Toledano, Inmaculada Alonso-García, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1

Scroll to top